NCT02135042 Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02124148 A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer Status COMPLETED Phase PHASE1
NCT02115152 Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer Status UNKNOWN Phase PHASE2
NCT02071069 Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT02059499 Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions Status COMPLETED Phase PHASE3
NCT02047474 Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02047201 Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC Status COMPLETED Phase PHASE2
NCT02042443 Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT02041481 MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT02037048 FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Chemoradiotherapy in Patients With Esophageal Adenocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02024607 A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02021422 A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy Status COMPLETED Phase PHASE1
NCT02017600 A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus Status TERMINATED Phase PHASE2
NCT01959672 Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01954992 Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Status RECRUITING Phase PHASE3
NCT01941173 Short-Infusion Ziv-aflibercept in Treating Patients With Metastatic Colorectal Cancer Receiving Combination Chemotherapy Status WITHDRAWN Phase NA
NCT01928290 Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal Cancer Status COMPLETED Phase PHASE2
NCT01897454 Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT01893294 Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT01880385 Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer Status UNKNOWN Phase PHASE1